Medicare Enrolled
Dr. Tina Zecca, DO
Allergy & Immunology · Little Silver, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zecca from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zecca?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zecca
Dr. Tina Zecca is an allergy & immunology specialist in Little Silver, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zecca performed 6,125 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Zecca received a total of $210,070 from 54 pharmaceutical and/or device companies across 1312 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zecca is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 24% volume in NJ
$210,070 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,125
Medicare services
Top 24% in NJ for allergy & immunology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
2,532 | $12 | $35 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
1,751 | $4 | $12 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
719 | $10 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
302 | $68 | $164 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
259 | $21 | $85 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $43 | $104 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
139 | $101 | $240 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
136 | $63 | $262 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
59 | $87 | $240 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $120 | $360 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $33 | $60 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
13 | $34 | $160 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
13 | $0 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$210,070
Total received (2018-2024)
Avg $30,010/year across 7 years
Top 4% in NJ for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
1,312
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$50,662
2023
$25,376
2022
$51,330
2021
$21,751
2020
$18,278
2019
$23,571
2018
$19,102
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$17,698
Grifols USA, LLC
$11,314
Optinose US, Inc.
$7,568
Hikma Pharmaceuticals USA
$6,549
GENZYME CORPORATION
$2,205
Cycle Pharmaceuticals Inc
$1,258
GlaxoSmithKline, LLC.
$471
Genentech USA, Inc.
$416
Regeneron Healthcare Solutions, Inc.
$360
PFIZER INC.
$347
Blueprint Medicines Corporation
$305
Incyte Corporation
$284
BioCryst US Sales Co., LLC
$269
Novartis Pharmaceuticals Corporation
$232
CSL Behring
$175
AIMMUNE THERAPEUTICS, INC.
$175
Takeda Pharmaceuticals U.S.A., Inc.
$170
LEO Pharma Inc.
$168
Amgen Inc.
$138
ABBVIE INC.
$113
AQUESTIVE THERAPEUTICS, INC.
$83
kaleo, Inc.
$81
Pharming Healthcare, Inc.
$77
Octapharma USA, Inc.
$45
Greer Laboratories, Inc.
$38
Alnylam Pharmaceuticals Inc.
$32
ADMA BioManufacturing LLC
$28
Insmed, Inc.
$16
Aytu BioPharma, Inc.
$15
ALK-Abello, Inc
$15
Lilly USA, LLC
$15
Top 3 companies account for 72.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$38,349
OptiNose US, Inc.
$34,289
Grifols USA, LLC
$27,847
Optinose US, Inc.
$25,456
Shire North American Group Inc
$21,381
Aimmune Therapeutics, Inc.
$21,161
Hikma Pharmaceuticals USA
$6,605
PFIZER INC.
$6,431
Takeda Pharmaceuticals U.S.A., Inc.
$5,177
Genentech USA, Inc.
$4,789
ALK-Abello, Inc
$3,174
GENZYME CORPORATION
$2,713
GlaxoSmithKline, LLC.
$2,402
Regeneron Healthcare Solutions, Inc.
$1,401
Cycle Pharmaceuticals Inc
$1,258
Eyevance Pharmaceuticals LLC
$1,183
Teva Pharmaceuticals USA, Inc.
$577
CSL Behring
$564
Novartis Pharmaceuticals Corporation
$516
Incyte Corporation
$449
AIMMUNE THERAPEUTICS, INC.
$393
Blueprint Medicines Corporation
$389
BioCryst US Sales Co., LLC
$370
Bio Products Laboratory USA, Inc.
$356
kaleo, Inc.
$320
Boehringer Ingelheim Pharmaceuticals, Inc.
$296
Amgen Inc.
$292
LEO Pharma Inc.
$285
ADMA BioManufacturing LLC
$190
Pharming Healthcare, Inc.
$162
Octapharma USA, Inc.
$130
Covis Pharma GmBH
$128
Covis Pharma B.V.
$116
ABBVIE INC.
$113
Kaleo, Inc.
$89
AQUESTIVE THERAPEUTICS, INC.
$83
Covis Pharma GmbH
$77
Phadia US Inc.
$68
Mylan Specialty L.P.
$63
Horizon Therapeutics plc
$56
Greer Laboratories, Inc.
$51
Aytu BioPharma, Inc.
$42
Merck Sharp & Dohme Corporation
$41
Alnylam Pharmaceuticals Inc.
$32
Merck Sharp & Dohme LLC
$30
Insmed, Inc.
$29
AbbVie Inc.
$28
AYTU BioPharma, Inc.
$26
Sunovion Pharmaceuticals Inc.
$24
Philips Electronics North America Corporation
$17
Lilly USA, LLC
$15
Bausch & Lomb, a division of Bausch Health US, LLC
$14
Circassia Pharmaceuticals Inc
$14
Horizon Pharma plc
$11
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTIMMUNE · ADBRY · AIRSUPRA · ALREX · ALVESCO · AMVUTTRA · ARALAST · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · Arikayce · Auvi-Q · BENLYSTA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dust mite (D. farinae) · Dymista · EBGLYSS · EOHILIA · EUCRISA · FASENRA · Flarex · GLASSIA · Gammaplex · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · ImmunoCAP · Karbinal · Kloxxado · NIOX VERO · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORALAIR · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PAXLOVID · PAZEO · Palforzia · Perforomist · ProAir Digihaler · Prolastin-C Liquid · RINVOQ · RUCONEST · Ragwitek · Ryaltris · SAJAZIR · SPIRIVA · SPIRIVA RESPIMAT · SYMBICORT · Sajazir · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Tobradex ST · Utibron · XOLAIR · Xembify · Xhance · Xolair · Yupelri · Zerviate
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Allergy & immunologists in nearby ZIP areas
59
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
RIVERVIEW MEDICAL CENTER
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zecca is a mixed practice specialist, with above-average Medicare volume (top 24% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zecca experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Zecca performed 2,532 allergy immunotherapy preparation services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Zecca receive payments from pharmaceutical companies?
Yes. Dr. Zecca received a total of $210,070 from 54 companies across 1,312 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zecca's costs compare to other allergy & immunologists in Little Silver?
Dr. Zecca's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zecca) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Allergy & Immunologists in Little Silver
Browse allergy & immunologists in Little Silver ranked by procedure volume and transparency data.
Highest volume
Top Allergy & Immunologists in NJ
Allergy & immunologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Allergy & Immunologists in NJ
Which NJ allergy & immunologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
OptiNose US, Inc. Payments to Doctors
See all physicians who received payments from OptiNose US, Inc.
By company
Grifols USA, LLC Payments to Doctors
See all physicians who received payments from Grifols USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology